查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1834149

DNA-RNA 樣品製備市場（按產品類型、技術、應用和最終用戶分類）—2025-2032 年全球預測

DNA-RNA Sample Preparation Market by Product Type, Technology, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，DNA-RNA 樣品製備市場將成長至 43.6 億美元，複合年成長率為 8.77%。

主要市場統計數據
基準年2024年 22.2億美元
預計2025年 24.2億美元
預測年份：2032年 43.6億美元
複合年成長率（%） 8.77%

權威介紹 DNA 和 RNA 樣本製備如何支援現代生命科學工作流程中的實驗室可靠性、提高通量和法規遵循

DNA 和 RNA 樣本製備是現代生命科學工作流程的基礎，推動著診斷、治療開發和基礎研究成果的進步。實驗室面臨越來越大的壓力，需要在控制成本和監管要求的同時，實現更高的通量、更高的重現性和可追溯的監管鏈。因此，樣品製備已從實驗室的常規流程發展成為定序、分子診斷和生物標記發現等下游研究成功的關鍵因素。

在臨床和研究環境中，對精簡流程和自動化的需求日益成長。酶學、緩衝液化學和提取硬體的技術進步減少了人工時間和差異性，但也帶來了兼容性、驗證和操作員培訓等方面的新考慮。同時，監管監控和品管的要求已延伸至分析前階段，迫使採購和營運團隊重新思考供應商的選擇、驗證通訊協定和供應的連續性。

此項採用透過強調實驗室領導者可用的營運和策略槓桿，為後續分析提供了框架。它強調了儀器、耗材設計和工作流程整合之間的相互作用，並指出需要進行細緻的評估，以平衡性能、整體擁有成本和對技術變革的準備程度。以下章節將對這些主題進行擴展，並深入探討重塑樣品製備的變革力量及其對決策者的實際意義。

自動化、試劑化學的進步、分散式測試和整合數位化工作流程如何改變全球實驗室的核酸樣品製備

樣品製備領域正經歷技術創新、營運需求和法規變革的交匯，從而徹底改變實驗室處理核酸的方式。自動化不再是高性能中心的專屬能力；相反，它已成為研究機構的策略重點，旨在降低變異性、提高通量並將熟練員工重新部署到更高價值的任務中。自動化工作站和整合平台正在簡化從提取到文庫製備的工作流程，從而為定序和診斷分析提供更一致的起始材料。

同時，化學和試劑領域的進步正在提高從高難度檢體中提取核酸的產量和完整性，並擴大可可靠處理的樣本範圍。緩衝液配方和酵素工程的創新正在促進更快的實驗方案和更高的抑制劑耐受性，從而提高基因組學和轉錄組學應用的下游性能。自動化相容套件和模組化實驗方案正在縮短週轉時間並簡化驗證。

另一個重大轉變是偵測能力的去中心化。照護現場和近患者診斷，加上分散式研究網路，正在推動對簡單、穩定、可在中心實驗室之外可靠操作的樣本製備解決方案的需求。這一趨勢促使供應商開發緊湊型儀器和預拌試劑，以最大限度地減少用戶操作差異。

最後，數位整合和數據驗證對於樣品製備策略至關重要。工作流程感知軟體、樣品追蹤以及與實驗室資訊管理系統的連接，能夠增強可追溯性並實現持續改進。因此，各組織優先考慮能夠提供生態系統方法的供應商和平台，該方法能夠將儀器、耗材和軟體連接起來，不僅提供高效能，還能提供可重複的結果和操作可見性。

評估美國不斷變化的關稅政策和貿易動態如何重塑採購彈性、供應商策略以及樣品製備作業的業務連續性

美國的關稅和貿易行動正在推動整個生命科學生態系統對彈性供應鏈和彈性籌資策略的需求。關稅結構的變化會影響儀器、套件和試劑採購的經濟性，進而影響庫存策略、供應商多元化和本地製造夥伴關係關係的決策。對於依賴及時交貨和可用投入的實驗室來說，關稅主導的成本變化可能會擾亂採購週期，並需要重新協商供應商合約。

關稅調整的累積影響將最顯著地體現在採用精實庫存模式的組織以及吸收額外成本能力有限的小型或新興供應商身上。為此，許多買家正在重新評估其供應商契約，以納入價格上漲條款、延長前置作業時間和緊急條款。同時，採購團隊和營運負責人正在探索近岸外包和多方採購，以降低單一國家生產和海關延誤的風險。

關稅趨勢的另一個後果是，人們對能夠在不同供應管道提供同等性能的替代產品架構和技術的興趣日益濃厚。例如，如果一種技術可用性更高或前置作業時間更短，實驗室可能會考慮在基於柱的萃取和磁分離之間切換。這種採購彈性必須與驗證負擔和臨床等效性要求相平衡，尤其是在受監管的診斷環境中。

重要的是，關稅帶來的成本壓力也促使供應商和最終用戶之間加強合作。隨著相關人員尋求穩定性，長期供應協議、聯合庫存規劃和策略性庫存緩衝正變得越來越普遍。這些方法，加上對供應商風險評估的日益重視，正在幫助實驗室應對不斷變化的貿易格局，在維護品質和合規標準的同時保持營運的連續性。

深入的細分洞察揭示了儀器、套件、試劑化學、核心技術、多樣化應用和不同的最終用戶如何推動差異化的採購和驗證優先級

詳細的產品細分視圖可以清楚地展現效能改善和採購複雜性之間的交集。產品類型包括儀器、套件和試劑。儀器包括自動化工作站和離心機，它們在吞吐量、佔地面積和整合潛力方面差異很大。套件包括文庫製備試劑套件和核酸萃取試劑套件，其中文庫製備試劑盒進一步分為DNA庫製備試劑盒和RNA文庫製備試劑套件，套件在酵素反應和處理要求方面有所不同。試劑涵蓋緩衝液和酶，這些化學物質決定了產量、完整性以及與下游檢測的兼容性。了解這些差異對於使採購與工作流程目標和驗證約束保持一致至關重要。

技術分類揭示了核酸分離純化的基本機制。柱層分離法因其簡單易用而在某些樣品類型中廣受歡迎，而磁分離法因其易於整合到機器人工作流程中，因其自動化和可擴展性而日益普及。沉澱法在某些注重成本效益和簡便性的應用中仍然效用。因此，技術選擇應根據樣品類型、通量需求和下游分析結果來決定。

依最終用途細分，凸顯了最終用途需求的多樣性。臨床診斷需要嚴格的驗證和可重複性，而基因檢測和感染疾病檢測等子領域則需要可靠的核酸回收和監管可追溯性。法醫工作流程著重於DNA指紋識別和RNA分析，特別注重樣本保存和監管鏈，而基因組學和轉錄組學研究應用通常優先考慮靈活性、靈敏度以及處理新樣本或劣化樣本的能力。這些不同的應用導致了性能規格和耗材規格的差異。

對最終用戶進行細分可以揭示不同的購買行為和檢驗優先順序。由研究機構和大學組成的學術機構通常優先考慮探索性工作的靈活性和成本效益。同時，包括生物製藥公司和生物技術新興企業在內的生物技術公司需要可擴展、可重複的解決方案來支援其產品開發時間表。醫院（包括臨床實驗室和診斷中心）需要經過驗證的合規試劑套件和工作流程，以及可預測的供應。大型和非專利藥公司都優先考慮一致性、批次控制和供應商可靠性，以支援臨床測試和製造流程。認知到這些最終用戶特徵，供應商可以根據每個客戶群的需求自訂產品系列、支援服務和驗證包裝。

美洲、歐洲、中東和非洲地區以及亞太地區的地理差異如何決定樣品製備解決方案的採購優先順序、驗證需求和區域市場方法

區域動態在塑造供應鏈、監管預期和樣品製備技術的採用率方面發揮著至關重要的作用。美洲地區擁有大量先進的臨床實驗室、研究機構和強大的生物技術部門，推動了對高性能自動化和檢驗套件的需求，而籌資策略強調與供應商的夥伴關係以及與區域機構保持一致的監管合規性。美洲地區也積極投資於紮根於本地的製造和分銷網路，以支援快速部署並管理海關和物流的複雜性。

歐洲、中東和非洲呈現出一種多元化的格局，某些國家的監管環境協調一致，而另一些國家的採購實踐則高度在地化。該地區對靈活的解決方案有著強烈的需求，這些解決方案能夠滿足不同的監管要求，並與不同的實驗室基礎設施相容。此外，歐洲、中東和非洲的實驗室越來越注重永續性、低溫運輸最佳化和供應商透明度，這影響著與減少耗材廢棄物和供應鏈可追溯性相關的採購決策。

亞太地區繼續以自動化技術的快速普及和本土製造商和供應商數量的成長為特徵。大量的科學研究投入、不斷提升的臨床檢測能力以及對基因組學和精準醫療的大量公共投資，正在加速設備和耗材的普及。然而，由於法律規範和檢體類型的區域差異，需要量身定做的驗證支援和客戶培訓計劃。這些地理差異凸顯了區域化打入市場策略、靈活的銷售模式以及強大的本地技術支援對於在不同地區成功推廣和持續使用的重要性。

競爭格局分析表明，平台整合、化學差異化、區域支援和策略夥伴關係將決定供應商實力和客戶偏好

DNA 和 RNA 樣本製備生態系統的競爭格局由成熟的儀器製造商、專業試劑供應商和敏捷的套件開發商共同構成。儀器領導者專注於平台整合、自動化功能和軟體驅動的工作流程管理，而試劑和試劑套件供應商則透過化學創新、易用性以及針對臨床診斷和法醫學分析等特定應用的驗證支援來脫穎而出。儀器和耗材供應商之間的策略聯盟和共同開發契約日益普遍，從而形成了簡化驗證並加速應用的捆綁解決方案。

規模較小、專注的參與企業通常透過提供利基化學優勢、低成本耗材或針對特定檢體類型或下游檢測最佳化的高度專業化套件來競爭。對於尋求全新性能特性的研究機構，或希望減少對單一供應商依賴的組織而言，此類供應商可能成為頗具吸引力的合作夥伴。同時，成熟的供應商則利用規模優勢，提供對臨床和製藥公司至關重要的擴展服務網路、監管文件和連續性保證。

另一個競爭維度是所提供的支援和訓練程度。提供全面驗證套件、實踐培訓和整合協助的供應商會受到缺乏廣泛內部方法轉移能力的客戶的青睞。此外，由於買家會考慮與供應商選擇相關的營運和合規風險，供應鏈實踐、品質系統和文件的透明度也變得越來越重要。總體而言，能夠將強大的技術性能、可靠的供應和強大的客戶支援相結合的公司最有能力滿足現代實驗室的多樣化需求。

為供應商和實驗室領導提供可行的策略建議，以增強彈性、簡化驗證並加速採用先進的樣品製備解決方案

產業領導者應優先考慮增強營運彈性、促進技術互通性並減少最終用戶驗證摩擦的策略。首先，投資支援多種萃取和文庫製備化學方法的模組化自動化平台，使客戶無需強制更換硬體即可調整工作流程。這種模組化應輔以開放介面和軟體API，以簡化與實驗室資訊系統和分析流程的整合。

其次，供應商和買家應在檢驗套件和標準化通訊協定合作，以加速採用。提供並行的性能數據、可操作的驗證包和詳盡的文檔，可以幫助臨床實驗室和實驗室更快、更安全地實現等效性。此外，開發培訓計劃和遠端支援功能可以減輕客戶的營運負擔，並提高長期滿意度。

第三，供應鏈策略必須不斷發展，以緩解地緣政治和關稅波動的影響。多元化生產佈局、建立區域分銷緩衝以及協商包含應急條款的供應合約都是謹慎之舉。買家也應考慮採用多種技術採購方式，以便在供應受限或成本壓力下，能夠在柱式、磁性和沈降技術之間交替使用。

最後，永續性和生命週期考量正在成為企業差異化的競爭優勢。減少消耗品廢棄物、最佳化試劑用量以及提供回收和再利用計劃，可以降低環境影響，並透過企業永續性吸引客戶。透過將產品開發、營運準備和客戶支援舉措與這些優先事項相結合，行業領導者可以增強其競爭優勢，並推動長期應用。

透明且嚴格的三角調查方法結合了訪談、技術評估、文獻綜述和比較評估，提供了可操作且可靠的見解

本分析整合了主要和次要研究、技術文獻和相關人員訪談，旨在建立對 DNA 和 RNA 樣品製備動態的實證理解。主要研究包括對臨床、法醫學和研究學科的實驗室主任、採購負責人和產品專家進行結構化訪談，並輔以對代表性工作流程中儀器性能和試劑穩定性的技術評估。這些對話數據與專家同行評審文獻和監管指南的仔細審查相輔相成，以確保符合當前的最佳實踐和合規性要求。

二次研究評估了已發布的產品規格、供應商技術說明和獨立效能測試，以檢驗關於吞吐量、週轉時間和技術相容性的聲明。可重複性、易於整合和檢驗支援是比較評估的關鍵標準。在某些情況下，我們運用使用案例和營運案例來說明技術選擇和籌資策略的實際意義。

此分析方法強調將定性相關人員洞察與技術文件進行交叉檢驗，並透過迭代改進來識別反覆出現的主題和痛點。我們注意避免依賴單一資訊來源的斷言，解釋性判斷是基於多種支持性輸入。最終的調查方法兼顧了技術嚴謹性與實務相關性，從而為實驗室經理、採購負責人和策略規劃人員提供了切實可行的建議。

總結性結論強調了彈性、可互通和經過驗證的樣品製備方法對於支持可靠的基因組和診斷結果的戰略重要性

總而言之，DNA和RNA樣本製備不再只是實驗室的日常事務，而是一個對下游基因組學和診斷工作流程的品質、速度和成本效益具有重大影響的策略性領域。自動化和試劑化學技術的進步正在拓展其能力，同時也提高了對供應連續性、檢驗支援以及與數位實驗室生態系統整合的期望。因此，供應商和最終用戶都必須採取整體觀點，優先考慮互通性、可追溯性和彈性。

採購和營運決策應基於對產品細分、技術權衡、特定應用需求和區域差異的清晰理解。適應關稅和供應鏈動態需要積極規劃，包括多元化採購和協作供應商關係。最終，投資於模組化平台、嚴格的驗證套件和強大的供應商夥伴關係關係的組織將能夠更好地將改進的樣品製備轉化為可靠的診斷結果、更短的研究時間和永續的業務成果。

前進的道路在於將技術創新與實際實施相結合——使實驗室能夠利用新的化學和自動化，而不會犧牲合規性或連續性——以便實驗室能夠充分發揮核酸分析在臨床、法醫學和研究領域的潛力。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 在臨床實驗室中實施自動化高通量 DNA 和 RNA 萃取系統
  • 整合磁珠純化工作流程，提高樣品純度與產量
  • 用於單細胞分析的低輸入RNA樣品製備的微流體平台的開發
  • 用於傳染病檢查的無污染核酸萃取試劑套件的需求不斷增加
  • 無酵素核酸沉澱方法的進步降低了成本和樣品處理時間
  • 客製化RNA穩定試劑用於現場部署病原體監測
  • 引入直接 PCR 樣本製備試劑套件，簡化診斷工作流程並減少手動步驟

第6章 2025年美國關稅的累積影響

第7章 人工智慧的累積影響，2025年

8. DNA-RNA 樣品製備市場（依產品類型）

  • 裝置
    • 自動化工作站
    • 離心機
  • 套件
    • 文庫製備試劑套件
      • DNA庫套件
      • RNA文庫試劑套件
    • 核酸萃取試劑套件
  • 試劑
    • 緩衝
    • 酵素

9. DNA-RNA樣品製備市場（依技術）

  • 基於列
  • 磁選
  • 沉澱法

第 10 章：DNA-RNA 樣本製備市場（依應用）

  • 臨床診斷
    • 基因檢測
    • 感染疾病
  • 法醫學
    • DNA指紋識別
    • RNA分析
  • 研究
    • 基因組學
    • 轉錄組學

第 11 章 DNA-RNA 樣本製備市場（依最終用戶）

  • 學術機構
    • 研究所
    • 大學
  • 生技公司
    • 生物製藥公司
    • 生技Start-Ups
  • 醫院
    • 臨床實驗室
    • 診斷中心
  • 製藥公司
    • 大型製藥公司
    • 學名藥

12. DNA-RNA樣品製備市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 13 章：DNA-RNA 樣本製備市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 14 章 DNA-RNA 樣本製備市場（按國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • QIAGEN NV
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • Promega Corporation
    • Takara Bio Inc.
    • New England Biolabs, Inc.
    • PerkinElmer, Inc.
Product Code: MRR-4348D129FA47

The DNA-RNA Sample Preparation Market is projected to grow by USD 4.36 billion at a CAGR of 8.77% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.22 billion
Estimated Year [2025] USD 2.42 billion
Forecast Year [2032] USD 4.36 billion
CAGR (%) 8.77%

An authoritative primer on how DNA and RNA sample preparation now underpins laboratory reliability, throughput scaling, and regulatory compliance across modern life science workflows

The preparation of DNA and RNA samples is foundational to modern life sciences workflows, driving outcomes in diagnostics, therapeutics development, and basic research. Laboratories are increasingly pressured to deliver higher throughput, greater reproducibility, and traceable chain-of-custody while managing cost and regulatory requirements. As a result, sample preparation has evolved from a routine laboratory step into a critical enabler of downstream success for sequencing, molecular diagnostics, and biomarker discovery.

Across clinical and research settings, the demand for streamlined procedures and automation has intensified. Technological advances in enzymology, buffer chemistry, and extraction hardware have reduced hands-on time and variability, yet they have also introduced new considerations around compatibility, validation, and operator training. In parallel, regulatory scrutiny and quality management expectations are extending into pre-analytical stages, prompting procurement and operations teams to rethink vendor selection, validation protocols, and supply continuity.

This introduction frames the subsequent analysis by highlighting the operational and strategic levers available to laboratory leaders. It underscores the interplay between instrumentation, consumable design, and workflow integration, and points to the need for a nuanced evaluation that balances performance, total cost of ownership, and future-proofing against technological shifts. The following sections expand on these themes, offering insight into the transformative forces reshaping sample preparation and practical implications for decision-makers.

How automation, reagent chemistry advances, decentralization of testing, and digital workflow integration are collectively transforming nucleic acid sample preparation practices in laboratories worldwide

Sample preparation is being reshaped by a convergence of technological innovation, operational demand, and regulatory evolution that together are driving transformational change in how laboratories approach nucleic acid handling. Automation is no longer a niche capability reserved for high-throughput centers; instead, it has become a strategic priority for institutions seeking to reduce variability, increase throughput, and redeploy skilled staff toward higher-value tasks. Automated workstations and integrated platforms are streamlining workflows from extraction through library preparation, enabling more consistent input material for sequencing and diagnostic assays.

Concurrently, chemistry and reagent advances are improving yield and integrity of nucleic acids extracted from challenging specimen types, extending the range of samples that can be processed reliably. Innovations in buffer formulations and enzyme engineering are driving faster protocols and greater resilience to inhibitors, which translates into improved downstream performance for both genomic and transcriptomic applications. These gains are complemented by methodological refinement in library preparation approaches, where automation-compatible kits and modular protocols are shortening turnaround time and simplifying validation.

Another significant shift is the decentralization of testing capabilities. Point-of-care and near-patient diagnostics, coupled with distributed research networks, are increasing demand for simplified, ruggedized sample preparation solutions that can operate reliably outside centralized laboratories. This trend is prompting suppliers to develop compact instruments and pre-formulated reagents that minimize user-dependent variability.

Finally, digital integration and data provenance are becoming intrinsic to sample preparation strategy. Workflow-aware software, sample tracking, and connectivity to laboratory information management systems are enhancing traceability and enabling continuous improvement. As a result, organizations are prioritizing vendors and platforms that offer not just performance but an ecosystem approach that aligns instrumentation, consumables, and software to deliver reproducible results and operational visibility.

Assessing how evolving tariff policies and trade dynamics in the United States are reshaping procurement resilience, supplier strategies, and operational continuity for sample preparation operations

Tariff policies and trade actions in the United States have amplified the need for resilient supply chains and adaptive sourcing strategies across the life sciences ecosystem. Changes in tariff structures affect the economics of procuring instruments, kits, and reagents, and they influence decisions regarding inventory strategy, vendor diversification, and localized manufacturing partnerships. For laboratories dependent on timely deliveries and validated inputs, tariff-driven cost shifts can disrupt procurement cycles and necessitate renegotiation of supplier agreements.

The cumulative impact of tariff adjustments is felt most acutely by organizations operating with lean inventory models and by small or emerging suppliers who may have limited ability to absorb added costs. In response, many buyers have sought to re-evaluate vendor contracts to incorporate price escalation clauses, extended lead times, and contingency provisions. At the same time, purchasing teams and operational leaders are exploring near-shoring and multi-sourcing arrangements to mitigate exposure to single-country production risks and customs delays.

Another consequence of tariff dynamics is accelerated interest in alternative product architectures and technologies that offer comparable performance with different supply pathways. For example, labs may consider switching between column-based extraction and magnetic separation chemistries if one route demonstrates superior availability or shorter lead times. This procurement flexibility must be balanced against validation burdens and clinical equivalence requirements, particularly in regulated diagnostic environments.

Importantly, tariff-induced cost pressures also incentivize greater collaboration between vendors and end users. Long-term supply agreements, joint inventory planning, and strategic stock buffering are becoming more common as stakeholders seek stability. These approaches, combined with an increased focus on supplier risk assessment, help laboratories maintain continuity of operations while navigating evolving trade conditions and protecting quality and compliance standards.

Deep segmentation insights revealing how instruments, kits, reagent chemistries, core technologies, varied applications, and heterogeneous end users drive differentiated procurement and validation priorities

A granular view of product segmentation clarifies where performance improvements and procurement complexity intersect. Product categories encompass instruments, kits, and reagents, with instruments including automated workstations and centrifuges that differ significantly in throughput, footprint, and integration potential. Kits cover library preparation kits and nucleic acid extraction kits, with library preparation further split into DNA and RNA library kits that have distinct enzymatic and handling requirements. Reagents span buffers and enzymes, the discrete chemistries that determine yield, integrity, and compatibility with downstream assays. Understanding these distinctions is essential for aligning procurement to workflow objectives and validation constraints.

Technological segmentation highlights the fundamental mechanisms by which nucleic acids are isolated and purified. Column-based methods remain prevalent for specific sample types due to their simplicity and familiarity, whereas magnetic separation has gained favor for automation and scalability because it is readily integrated into robotic workflows. Precipitation techniques retain utility for certain applications where cost-effectiveness and simplicity are prioritized. Each technology path brings trade-offs in terms of hands-on time, equipment compatibility, and susceptibility to inhibitors, therefore technology choice should be informed by sample type, throughput needs, and downstream analytics.

Application-based segmentation emphasizes the diversity of end-use requirements. Clinical diagnostics require stringent validation and reproducibility, with subdomains in genetic testing and infectious disease detection demanding reliable nucleic acid recovery and regulatory traceability. Forensics workflows focus on DNA fingerprinting and RNA analysis with particular attention to sample preservation and chain-of-custody, while research applications in genomics and transcriptomics often prioritize flexibility, sensitivity, and the ability to handle novel or degraded samples. These application distinctions drive different performance specifications and consumable formats.

End-user segmentation reveals divergent purchasing behaviors and validation priorities. Academic institutes, comprising research institutions and universities, typically prioritize flexibility and cost-effectiveness for exploratory work, whereas biotechnology companies-spanning biopharma firms and biotech startups-require scalable, reproducible solutions that support product development timelines. Hospitals, including clinical labs and diagnostic centers, demand validated, regulatory-compliant kits and workflows with predictable supply. Pharmaceutical companies, both major firms and generic manufacturers, emphasize consistency, batch control, and supplier reliability to support clinical trials and manufacturing processes. Recognizing these end-user characteristics allows suppliers to tailor product portfolios, support services, and validation packages to the needs of distinct customer segments.

How geographic differences across the Americas, EMEA, and Asia-Pacific determine procurement priorities, validation needs, and regional go-to-market approaches for sample preparation solutions

Regional dynamics play a decisive role in shaping supply chains, regulatory expectations, and adoption rates for sample preparation technologies. In the Americas, a concentration of advanced clinical laboratories, research institutions, and a strong biotech sector drives demand for high-throughput automation and validated kits, while procurement strategies emphasize supplier partnerships and regulatory compliance that aligns with regional agencies. The Americas also exhibits active investment in localized manufacturing and distribution networks to support rapid deployment and to manage tariff and logistics complexity.

Europe, the Middle East, and Africa present a heterogeneous landscape where regulatory harmonization across certain countries contrasts with highly localized procurement practices in others. This region demonstrates strong demand for flexible solutions that can meet diverse regulatory requirements and operate across varying laboratory infrastructures. Moreover, EMEA institutions are increasingly focused on sustainability, cold-chain optimization, and vendor transparency, which influences purchasing decisions related to consumable waste reduction and supply chain traceability.

Asia-Pacific continues to be characterized by rapid adoption of automation and a growing base of domestic manufacturers and suppliers. High-volume research initiatives, expanding clinical testing capacity, and substantial public investment in genomics and precision medicine accelerate uptake of both instruments and consumables. However, regional diversity in regulatory frameworks and specimen types necessitates tailored validation support and localized customer training programs. Collectively, these geographic distinctions underscore the importance of regionalized go-to-market strategies, flexible distribution models, and robust local technical support to ensure successful implementation and sustained usage across different territories.

Competitive landscape analysis showing how platform integration, chemistry differentiation, localized support, and strategic partnerships determine supplier strength and customer preference

Competitive dynamics within the DNA and RNA sample preparation ecosystem are defined by a mix of established instrument manufacturers, specialized reagent suppliers, and agile kit developers. Leaders in instrumentation concentrate on platform integration, automation capabilities, and software-enabled workflow management, while reagent and kit providers differentiate through chemistry innovation, ease-of-use, and validation support for specific applications such as clinical diagnostics or forensic analysis. Strategic alliances and co-development agreements between instrument and consumable vendors are increasingly common, creating bundled solutions that simplify validation and accelerate adoption.

Smaller, focused entrants often compete by offering niche chemistry advantages, lower-cost consumables, or highly specialized kits optimized for particular specimen types or downstream assays. These suppliers can be attractive partners for research institutions seeking novel performance characteristics or for organizations aiming to reduce dependency on single-source providers. At the same time, established suppliers leverage scale to provide extended service networks, regulatory documentation, and continuity assurances that are critical to clinical and pharmaceutical customers.

An additional competitive axis is the degree of support and training provided. Vendors that offer comprehensive validation kits, hands-on training, and integration assistance gain traction with customers who lack internal capacity for extensive method transfer. Furthermore, transparency in supply chain practices, quality systems, and documentation is increasingly important, as buyers weigh the operational and compliance risks associated with vendor selection. Overall, companies that can combine robust technical performance with supply reliability and strong customer support are best positioned to meet the diverse needs of contemporary laboratories.

Actionable strategic recommendations for suppliers and laboratory leaders to enhance resilience, streamline validation, and accelerate adoption of advanced sample preparation solutions

Industry leaders should prioritize strategies that enhance operational resilience, promote technological interoperability, and reduce validation friction for end users. First, investing in modular automation platforms that support multiple extraction and library preparation chemistries will enable customers to adapt workflows without wholesale hardware replacement, thereby protecting installed bases and reducing procurement barriers. Such modularity should be complemented by open interfaces and software APIs to simplify integration with laboratory information systems and analytics pipelines.

Second, suppliers and buyers alike should collaborate on validation toolkits and standardized protocols that shorten adoption timelines. Providing side-by-side performance data, ready-to-run validation packs, and thorough documentation helps clinical and research laboratories achieve equivalence faster and with lower risk. In addition, developing training programs and remote support capabilities will reduce the operational burden on customers and improve long-term satisfaction.

Third, supply chain strategies must evolve to mitigate geopolitical and tariff-related disruptions. Diversifying manufacturing footprints, establishing regional distribution buffers, and negotiating supply agreements with contingency clauses are prudent steps. Buyers should also consider multi-technology procurement approaches that permit substitution between column-based, magnetic, or precipitation methods when supply constraints or cost pressures arise, while ensuring that substitution pathways are validated for critical applications.

Finally, sustainability and lifecycle considerations are becoming business differentiators. Reducing consumable waste, optimizing reagent volumes, and offering take-back or recycling programs can lower environmental impact and appeal to customers with institutional sustainability commitments. By aligning product development, operational readiness, and customer support initiatives with these priorities, industry leaders can strengthen competitive positioning and drive long-term adoption.

A transparent and rigorously triangulated research methodology combining interviews, technical assessments, literature review, and comparative evaluation to ensure actionable and reliable insights

This analysis synthesizes primary and secondary research, technical literature, and stakeholder interviews to build an evidence-based understanding of DNA and RNA sample preparation dynamics. Primary inputs included structured interviews with laboratory directors, procurement leads, and product specialists across clinical, forensic, and research domains, supplemented by technical assessments of instrument performance and reagent robustness in representative workflows. These conversational data were complemented by careful review of peer-reviewed literature and regulatory guidance to ensure alignment with current best practices and compliance expectations.

Secondary investigation involved evaluating publicly available product specifications, vendor technical notes, and independent performance studies to triangulate claims regarding throughput, hands-on time, and compatibility across technologies. Comparative assessments prioritized reproducibility, ease of integration, and validation support as key decision criteria. Where applicable, case studies and operational anecdotes were used to illustrate practical implications of technology choices and procurement strategies.

Analytical methods emphasized cross-validation between qualitative stakeholder insights and technical documentation, with iterative refinement to identify recurring themes and pain points. Care was taken to avoid reliance on single-source assertions, and interpretive judgments were grounded in multiple corroborating inputs. The resulting methodology balances technical rigor with pragmatic relevance, ensuring that recommendations are actionable for laboratory managers, procurement officers, and strategic planners.

Concluding synthesis emphasizing the strategic importance of resilient, interoperable, and validated sample preparation practices to support reliable genomic and diagnostic outcomes

In sum, DNA and RNA sample preparation is no longer a transactional laboratory activity but a strategic domain that materially influences the quality, speed, and cost-effectiveness of downstream genomic and diagnostic workflows. Technological advances in automation and reagent chemistry have expanded capability while simultaneously raising expectations for supply continuity, validation support, and integration with digital laboratory ecosystems. As a consequence, both suppliers and end users must adopt a holistic perspective that prioritizes interoperability, traceability, and resilience.

Procurement and operational decisions should be informed by a clear understanding of product segmentation, technology trade-offs, application-specific requirements, and regional nuances. Adapting to tariff and supply-chain dynamics requires proactive planning, including diversified sourcing and collaborative supplier relationships. Ultimately, organizations that invest in modular platforms, rigorous validation toolkits, and robust supplier partnerships will be better positioned to translate sample preparation improvements into reliable diagnostic outcomes, accelerated research timelines, and sustainable operational performance.

The path forward lies in harmonizing innovation with practical implementation: enabling laboratories to harness new chemistries and automation without sacrificing compliance or continuity. By doing so, institutions can realize the full potential of nucleic acid analyses across clinical, forensic, and research applications.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of automated high-throughput DNA and RNA extraction systems in clinical labs
  • 5.2. Integration of magnetic bead-based purification workflows for improved sample purity and yield
  • 5.3. Development of microfluidic platforms for low-input RNA sample preparation in single-cell analysis
  • 5.4. Growing demand for contamination-free nucleic acid extraction kits for infectious disease testing
  • 5.5. Advances in enzyme-free nucleic acid precipitation methods to reduce costs and sample processing time
  • 5.6. Customization of RNA stabilization reagents for field-deployable pathogen surveillance applications
  • 5.7. Implementation of direct-to-PCR sample preparation kits to streamline diagnostic workflows and reduce hands-on steps

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. DNA-RNA Sample Preparation Market, by Product Type

  • 8.1. Instruments
    • 8.1.1. Automated Workstations
    • 8.1.2. Centrifuges
  • 8.2. Kits
    • 8.2.1. Library Preparation Kits
      • 8.2.1.1. Dna Library Kits
      • 8.2.1.2. Rna Library Kits
    • 8.2.2. Nucleic Acid Extraction Kits
  • 8.3. Reagents
    • 8.3.1. Buffers
    • 8.3.2. Enzymes

9. DNA-RNA Sample Preparation Market, by Technology

  • 9.1. Column Based
  • 9.2. Magnetic Separation
  • 9.3. Precipitation

10. DNA-RNA Sample Preparation Market, by Application

  • 10.1. Clinical Diagnostics
    • 10.1.1. Genetic Testing
    • 10.1.2. Infectious Diseases
  • 10.2. Forensics
    • 10.2.1. Dna Fingerprinting
    • 10.2.2. Rna Analysis
  • 10.3. Research
    • 10.3.1. Genomics
    • 10.3.2. Transcriptomics

11. DNA-RNA Sample Preparation Market, by End User

  • 11.1. Academic Institutes
    • 11.1.1. Research Institutions
    • 11.1.2. Universities
  • 11.2. Biotechnology Companies
    • 11.2.1. Biopharma Firms
    • 11.2.2. Biotech Startups
  • 11.3. Hospitals
    • 11.3.1. Clinical Labs
    • 11.3.2. Diagnostic Centers
  • 11.4. Pharmaceutical Companies
    • 11.4.1. Big Pharma
    • 11.4.2. Generic Pharma

12. DNA-RNA Sample Preparation Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. DNA-RNA Sample Preparation Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. DNA-RNA Sample Preparation Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Thermo Fisher Scientific Inc.
    • 15.3.2. Merck KGaA
    • 15.3.3. QIAGEN N.V.
    • 15.3.4. Danaher Corporation
    • 15.3.5. Agilent Technologies, Inc.
    • 15.3.6. Bio-Rad Laboratories, Inc.
    • 15.3.7. Promega Corporation
    • 15.3.8. Takara Bio Inc.
    • 15.3.9. New England Biolabs, Inc.
    • 15.3.10. PerkinElmer, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. DNA-RNA SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. DNA-RNA SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. DNA-RNA SAMPLE PREPARATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA LIBRARY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA LIBRARY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA LIBRARY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA LIBRARY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA LIBRARY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA LIBRARY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY NUCLEIC ACID EXTRACTION KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY NUCLEIC ACID EXTRACTION KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY NUCLEIC ACID EXTRACTION KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY NUCLEIC ACID EXTRACTION KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY NUCLEIC ACID EXTRACTION KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY NUCLEIC ACID EXTRACTION KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BUFFERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BUFFERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BUFFERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BUFFERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BUFFERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BUFFERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC SEPARATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC SEPARATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC SEPARATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC SEPARATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC SEPARATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC SEPARATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRECIPITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRECIPITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRECIPITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRECIPITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRECIPITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRECIPITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA FINGERPRINTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA FINGERPRINTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA FINGERPRINTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA FINGERPRINTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA FINGERPRINTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA FINGERPRINTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TRANSCRIPTOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TRANSCRIPTOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TRANSCRIPTOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TRANSCRIPTOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOPHARMA FIRMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOPHARMA FIRMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOPHARMA FIRMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOPHARMA FIRMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOPHARMA FIRMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOPHARMA FIRMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECH STARTUPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECH STARTUPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECH STARTUPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECH STARTUPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECH STARTUPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECH STARTUPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIG PHARMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIG PHARMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIG PHARMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIG PHARMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIG PHARMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENERIC PHARMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENERIC PHARMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENERIC PHARMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENERIC PHARMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENERIC PHARMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENERIC PHARMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA DN